Nur77 is a druggable target, with several ligands being explored for treatment of diseases such as cancer, metabolic disorders, hyperinflammatory responses and endometriosis (Wu and Chen, 2018; Mohankumar et al., 2020). The gene discussed is NR4A1; the disease is Other metabolic disease.